RxSight (RXST) Long-Term Deferred Tax (2023)
RxSight's (RXST) quarterly Long-Term Deferred Tax came in at $646000.0 in Q4 2023.
RxSight (RXST) Long-Term Deferred Tax (2023) Analysis & Trends
RxSight (RXST) has 1 years of Long-Term Deferred Tax data on file, last reported at $646000.0 in Q4 2023.
- Quarterly Long-Term Deferred Tax changed N/A year-over-year to $646000.0 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $646000.0 (changed N/A YoY) and the FY2023 annual result came in at $646000.0, changed N/A from the prior year.
- Long-Term Deferred Tax steadied at $646000.0 in Q4 2023.
- In the past five years, Long-Term Deferred Tax ranged from a high of $646000.0 in Q4 2023 to a low of $646000.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | RxSight | 250.81 Mn | -153.43 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 646,000.00 |